ENAGenomicsSurgery, St Jude Children's Research Hospitalhttps://www.ebi.ac.uk/ena/browser/view/PRJNA630986Homo sapiensxref:PubMed:34893606KDM6B inhibition shows anticancer activity in neuroblastoma models. However, the acting mechanism of KDM6B inhibition remains poorly understood. We used microarray to detail the global programme of gene expression underlying anticancer activity of KDM6B inhibition in neuroblastoma cells. Overall design: BE2C cells were treated with GSK-J4 and KDM6B knockdown for RNA extraction and hybridization on Affymetrix microarrays.ENAJMJD3, BC038313, data, BE(2)_C, BE(2)-C cell, GSKJ4 compound, BE2-C, mKIAA0346, BE2C, BE2_C, 1700064E03Rik., Jmjd3, BE(2) C, CellJMJD3, BC038313, data, BE(2)_C, BE(2)-C cell, GSKJ4 compound, BE2-C, mKIAA0346, BE2C, BE2_C, 1700064E03Rik., Jmjd3, BE(2) C, CellfalseExpression data from BE2C cells treated with GSK-J4 and KDM6B knockdownExpression data from BE2C cells treated with GSK-J4 and KDM6B knockdown2025-09-242021-11-05PRJNA630986GSE150045960634893606